Mark Chin's Net Worth
Mark Chin's net worth is estimated to be at least $8,686,965.57 as of 12/23/2024. CoreStreet's estimation of Mark Chin's net worth is based on their sale of stock and current holding of stock.
Mark Chin is Director at Pyxis Oncology Inc. They have executed at least 5 trades of stock as per SEC Form 4 filings. Their most recent trade was for 1,745,761 units of PYXS stock on 04/21/2022. Their biggest sale was on 04/21/2022 when they sold 1,745,761 units of Pyxis Oncology Inc stock for $5,324,571.05. They typically trade 1 times per year.
Total value of insider buys:
- $353,800.00
Total value of insider sells:
- $8,333,165.57
Most recent insider trade:
- April 21, 2022
Mark Chin's Insider Trading History
| Pyxis Oncology Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
April 21, 2022 | Director | 1,745,761 | $3.05 | Sell | $5,324,571.05 |
| Harpoon Therapeutics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Dec. 17, 2019 | Director | 12,476 | $16.83 | Sell | $209,971.08 |
Dec. 9, 2019 | Director | 103,754 | $18.16 | Sell | $1,884,172.64 |
Dec. 6, 2019 | Director | 47,752 | $19.15 | Sell | $914,450.80 |
| Iterum Therapeutics PLC | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Oct. 30, 2018 | Director | 58,000 | $6.10 | Buy | $353,800.00 |